Family-based and Adolescent Residential Drug Treatment (ART)
|ClinicalTrials.gov Identifier: NCT01737632|
Recruitment Status : Completed
First Posted : November 29, 2012
Last Update Posted : November 29, 2012
|Condition or disease||Intervention/treatment||Phase|
|Substance Use Delinquency||Behavioral: Multidimensional Family Therapy (MDFT) Behavioral: Adolescent Residential Treatment||Not Applicable|
Aim 1: To compare the effectiveness of residential treatment with outpatient, family-based treatment multiple outcomes including substance use, mental health, school functioning, family function and delinquency among dually diagnosed adolescents.
Hypothesis 1. From intake to 2 months, residential treatment will show better outcomes than the family based treatment. Between 2 months and 18 months, family based treatment will show better outcomes than residential. Between 18 months and four years post intake, outpatient family based treatment will maintain its treatment gains, while the residential treatment condition will show an increase in these same symptoms and behaviors.
Aim 2: To examine the relationship between predictors (family, peer, educational/vocational functioning and involvement in post-treatment services), and outcomes (drug use, co-morbid symptoms, and criminal behavior) during the four-year post intake period.
Hypothesis 2a. Family functioning, educational/vocational functioning, and peer relationships measured at discharge will predict drug use, co-morbid symptoms, and criminal behaviors though the four year longer term follow up period.
Hypothesis 2b. Family functioning, educational/vocational functioning, peer relationships, and involvement in post-treatment services during the post treatment period will predict drug use, co-morbid symptoms, and criminal behavior through the longer term follow up period.
Research Question 1. Is the rate of change in family functioning, educational/vocational functioning, peer relationships, and involvement in post-treatment services related to the rate of change in drug use, co-morbid symptoms, and criminal behavior?
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||113 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Family-Based Versus Adolescent Residential Drug Treatment|
|Study Start Date :||August 2000|
|Actual Primary Completion Date :||June 2008|
|Actual Study Completion Date :||June 2010|
Experimental: Multidimensional Family Therapy (MDFT)
MDFT is an intensive, in-home family-based drug abuse treatment for adolescent substance abusers. MDFT views family factors in their context -in terms of the network (individual, familial, peer, community) or multiplicity of influences on drug use and change.
Behavioral: Multidimensional Family Therapy (MDFT)
MDFT assesses and intervenes in five domains: 1) Interventions with the adolescent, 2) interventions with the parent, 3) interventions to improve the parent-adolescent relationship, 4) interventions with other family members, and 5) interventions with external systems.
Adolescent Residential Treatment
The Adolescent Treatment Program (ATP) is a residential dual diagnosed substance abuse treatment program that is staff secure. It is based on a social learning approach which emphasizes positive reinforcement for appropriate coping behavior and social skills, and incorporates a "levels" system which allocates privileges and responsibilities according to the individual's behavioral capacities.
Behavioral: Adolescent Residential Treatment
The Adolescent Treatment Program targets the adolescent's abuse or dependency on chemicals while simultaneously treating the comorbid symptomatology found in dual diagnosed patients. These goals are accomplished by using four primary forms of intervention: (1) Chemical Education; (2) Group, Individual and Family Counseling; (3) Twelve Step Work; and 4) Psychotropic Medication for Clinical Symptomatology Comorbid with Substance Abuse.
- Change in Personal Involvement with Chemicals [ Time Frame: Baseline, 2, 4, 12, 18, 24, 36 and 48 months after baseline ]Scale from the Personal Experience Inventory (PEI) developed by Ken Winter.
- Change in substance use consumption [ Time Frame: Baseline, 2, 4, 12,18,24,36,48 months after intake ]Measure of substance use consumption as measured by the Timeline Follow-back Method.
- Change in externalizing symptoms [ Time Frame: Baseline, 2, 4, 12, 18, 24, 36 and 48 months ]Externalizing symptoms measured by the Youth Self Report
- Change in delinquency [ Time Frame: Intake, 2, 4, 12, 18, 24, 35, 48 months after intake ]Measured by youth report on the Self Report Delinquency Scale.
- Change in internalzing symptoms [ Time Frame: Intake, 2, 4, 12, 18, 24, 36, 48 months after baseline ]Measured by the Youth Self Report (YSR)
- Change in family conflict [ Time Frame: Baseline, 2, 4, 12, 18, 24, 36, 48 months after baseline ]Parent and youth report on their family conflict as measured by the Family Environment Scale.
- Change in parenting practices [ Time Frame: Baseline, 2, 4, 12, 18, 24,36, 48 months after baseline ]Measures the extent to which parents monitor, set limits, and provide affection to their teens.
- Change in family cohesion [ Time Frame: Intake, 2, 4, 12, 18, 24, 26, 48 months after intake ]Youth and parent reports of family closeness measured by the Family Environment Scale (FES)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01737632
|United States, Florida|
|University of Miami Miller School of Medicine|
|Miami, Florida, United States, 33136|
|The Village, Inc.|
|Miami, Florida, United States, 33137|
|Principal Investigator:||Howard A Liddle, EdD||University of Miami|